Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders (Q28263028)

Expert Opinion on Pharmacotherapy

Europe PubMed Central

title

Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders (English)

0 references

1 reference

Ingrid Bacher

1

0 references

Becky Wu

series ordinal

2

0 references

Douglas R Shytle

series ordinal

3

0 references

Tony P George

series ordinal

4

0 references

language of work or name

English

0 references

publication date

November 2009

0 references

published in

0 references

volume

10

0 references

issue

16

0 references

page(s)

2709-21

0 references

cites work

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine and nicotinic receptor involvement in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mammalian nicotinic acetylcholine receptors: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Diisopropylfluorophosphate and tetanic stimulation fail to reverse mecamylamine antagonism of Renshaw cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine: new therapeutic uses and toxicity/risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine (Inversine): an old antihypertensive with new research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Ketamine catalepsy and anesthesia in dogs pretreated with antiserotonergic or antidopaminergic neuroleptics or with anticholinergic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Co-morbidity of smoking in patients with psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

A cholinergic-adrenergic hypothesis of mania and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine activates and desensitizes midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Dopamine responsiveness to drugs of abuse: A shell‐core investigation in the nucleus accumbens of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine-mecamylamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine does not precipitate withdrawal in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine acutely increases human intravenous nicotine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine moderates cue-induced emotional responses in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Precessation treatment with nicotine skin patch facilitates smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Effects of smoking abstinence on visuospatial working memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Impairment of reward-related learning by cholinergic cell ablation in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

An acute dose of nicotine enhances cue-induced cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Varenicline reduces alcohol self-administration in heavy-drinking smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Intravenous nicotine in Alzheimer's disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Acute nicotinic blockade produces cognitive impairment in normal humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine for the treatment of Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine effects on adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Mecamylamine in Tourette's syndrome: a two-year retrospective case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The Epidemiology of Autism Spectrum Disorders *

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Molecular analysis of nicotinic receptor expression in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotinic cholinergic antagonists: a novel approach for the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

The status of pharmacotherapy for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Exaggeration of epileptic-like patterns by nicotine receptor activation during the GABA withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotine induced seizures blocked by mecamylamine and its stereoisomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102

Nicotinic acetylcholine receptors as targets for antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903329102